TELA Bio (TELA) Operating Expenses (2018 - 2026)

TELA Bio has reported Operating Expenses for 9 years, with the latest figure at $23.0 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses changed 0.27% year-over-year to $23.0 million; the trailing twelve-month figure through Mar 2026 stood at $88.2 million (up 0.84% YoY), and the FY2025 full-year result was $88.1 million, changed 0.1% from the prior year.
• Operating Expenses for Q1 2026 stood at $23.0 million, up from $20.4 million in the prior quarter.
• The five-year high for Operating Expenses was $23.9 million in Q4 2023, with the low at $14.8 million in Q1 2022.
• Average Operating Expenses over 5 years is $20.6 million, with a median of $20.6 million recorded in 2023.
• Year-over-year, Operating Expenses surged 42.19% in 2022 and slipped 18.1% in 2024.
• Tracing TELA's Operating Expenses over 5 years: stood at $17.6 million in 2022, then jumped by 35.69% to $23.9 million in 2023, then fell by 18.1% to $19.6 million in 2024, then grew by 4.23% to $20.4 million in 2025, then advanced by 12.95% to $23.0 million in 2026.
• The last three Operating Expenses figures came in at $23.0 million (Q1 2026), $20.4 million (Q4 2025), and $21.5 million (Q3 2025), per Business Quant data.

Peer Comparison